GENERAL DESCRIPTION:
Thym-Uvocal contains protein-free dry substances
from calf thymus extract; these are a standardized combination of thymus peptides, which
may replace the decrease of thymic secretion associated with
increasing age. The thymus gland undergoes an agerelated
decrease in production of its various peptides. As thymus factors have been correlated with
the strength of the immune system, Thym-Uvocal may help to
boost the immune system. It appears to have a
favorable action on the T-4/T-8 cell
ratio, and thus a stimulating and modulating action on the
cellular immune system. Thym-uvocal
increases levels of antibodies and phagocytosis,
increases interleukin-1 production, and activates macrophages and enhances their tumor cell
destruction action.
ROLE FOR ANTI-AGING:
Thym-Uvocal’s anti-aging benefits may include improved strength of the immune system, an
increase in the thymic peptide blood count, prevention and
treatment of infection, treatment of cancer, treatment of
rheumatic disease, treatment of dermatology disorders such as neurodermatitis, aphthosis and
psoriasis, treatment of allergic reaction and states of
exhaustion, and management of AIDS.
The elderly are the most important target
group for the administration of Thym-Uvocal and Thym-Uvocal’s main indications are diseases of
old age.
THERAPEUTIC DAILY AMOUNT:
Thym-Uvocal is available in 2ml ampules, topical cream, and 240mg tablets. Mulli of Germany
manufactures it.
MAXIMUM SAFE LEVEL:
established
SIDE EFFECTS/CONTRAINDICATIONS:
There is a possibility of allergic minor reactions.
Thym-Uvocal should not be administered to patients with thymic hyperfunction, such as
myasthenia gravis, thymic tumors, and
hypothyroidism.
